These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25741719)

  • 1. From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases.
    Roselli F; Caroni P
    Neuron; 2015 Mar; 85(5):901-10. PubMed ID: 25741719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.
    Saxena S; Caroni P
    Neuron; 2011 Jul; 71(1):35-48. PubMed ID: 21745636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium ions in neuronal degeneration.
    Wojda U; Salinska E; Kuznicki J
    IUBMB Life; 2008 Sep; 60(9):575-90. PubMed ID: 18478527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of calcium in physiology and pathology of neurons].
    Salińska E; Łazarewicz JW
    Postepy Biochem; 2012; 58(4):403-17. PubMed ID: 23662434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological analysis of target-related sympathetic pathways--from animal to human: similarities and differences.
    Jänig W; Häbler HJ
    Acta Physiol Scand; 2003 Mar; 177(3):255-74. PubMed ID: 12608996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacologic aspects of apoptosis: significance for neurodegenerative diseases.
    Michel PP; Lambeng N; Ruberg M
    Clin Neuropharmacol; 1999; 22(3):137-50. PubMed ID: 10367178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenal axis, glucocorticoids, and neurologic disease.
    Herman JP; Seroogy K
    Neurol Clin; 2006 Aug; 24(3):461-81, vi. PubMed ID: 16877118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: diseases of the brain--neuronal function and dysfunction.
    Tavernarakis N
    Biotechnol J; 2007 May; 2(5):518-9. PubMed ID: 17479972
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intracellular signaling pathways, apoptosis and neurodegenerative diseases].
    Marcilhac A
    Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):203-14. PubMed ID: 15689335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG
    Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective vulnerability in neurodegenerative diseases.
    Fu H; Hardy J; Duff KE
    Nat Neurosci; 2018 Oct; 21(10):1350-1358. PubMed ID: 30250262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic factors in the selective vulnerability of hippocampal pyramidal neurons.
    Mattson MP; Guthrie PB; Kater SB
    Prog Clin Biol Res; 1989; 317():333-51. PubMed ID: 2690106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in neurodegenerative disorders.
    Mattson MP
    Nat Rev Mol Cell Biol; 2000 Nov; 1(2):120-9. PubMed ID: 11253364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of molecular signaling for protein translation control in neurodegenerative diseases.
    Chang RC; Yu MS; Lai CS
    Neurosignals; 2006-2007; 15(5):249-58. PubMed ID: 17496426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron and ER stress in neurodegenerative disease.
    Liu Y; Connor JR
    Biometals; 2012 Aug; 25(4):837-45. PubMed ID: 22526559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity-dependent energy budget for neocortical signaling: effect of short-term synaptic plasticity on the energy expended by spiking and synaptic activity.
    DiNuzzo M; Giove F
    J Neurosci Res; 2012 Nov; 90(11):2094-102. PubMed ID: 22740502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?
    Bassil F; Fernagut PO; Bezard E; Meissner WG
    Prog Neurobiol; 2014 Jul; 118():1-18. PubMed ID: 24582776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting erythropoietin for chronic neurodegenerative diseases.
    Chong ZZ; Shang YC; Mu Y; Cui S; Yao Q; Maiese K
    Expert Opin Ther Targets; 2013 Jun; 17(6):707-20. PubMed ID: 23510463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitotoxicity: bridge to various triggers in neurodegenerative disorders.
    Mehta A; Prabhakar M; Kumar P; Deshmukh R; Sharma PL
    Eur J Pharmacol; 2013 Jan; 698(1-3):6-18. PubMed ID: 23123057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.